Elite Pharmaceuticals to Present SequestOx™ Data at the American Pain Society 35th Annual Scientific Meeting
May 09, 2016 07:30 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today it will present data for SequestOx™ (ELI-200) at the American...
Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
May 04, 2016 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., May 04, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Davis S. Caskey to...
Elite Pharmaceuticals Announces Changes to their Board of Directors
April 12, 2016 08:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., April 12, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced today that its Board of Directors has appointed Eugene Pfeifer to...
Elite Announces U.S. FDA Priority Review Designation for SequestOx™ NDA
March 17, 2016 07:00 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., March 17, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) today announced that the New Drug Application (NDA) for SequestOXTM...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Third Quarter of Fiscal Year 2016
February 09, 2016 16:31 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 09, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended December 31, 2015, the third quarter...
Elite Pharmaceuticals, Inc. to Host Conference Call to Discuss 3rd Quarter 2016 Financial Results on February 10, 2016
February 05, 2016 12:42 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Feb. 05, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
FDA Approves Waiver of NDA Filing Fee for Elite Pharmaceuticals
January 13, 2016 16:51 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- The United State Food and Drug Administration (“FDA”) granted Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) a waiver of the...
Nasrat Hakim Named Chairman of Board of Directors for Elite Pharmaceuticals
January 13, 2016 09:24 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 13, 2016 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP) announced that Jerry Treppel has resigned as the Company’s Chairman and as a...
Elite Pharmaceuticals, Inc. Reports Strong Growth for Second Quarter of Fiscal Year 2016
November 09, 2015 16:37 ET
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 09, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), announced results for the quarter ended September 30, 2015, the second...
Elite Pharmaceuticals, Inc. to Host Conference Call and Webcast to Discuss 2nd Quarter 2016 Financial Results on November 10, 2015
November 05, 2015 17:12 ET
|
Elite Pharmaceuticals, Inc.
Northvale, NJ, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCQB: ELTP), a specialty pharmaceutical company developing a pipeline of...